共 176 条
[1]
Black DM(2020)Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates N Engl J Med 383 743-753
[2]
Geiger EJ(2019)Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review BMC Cancer 19 980-23
[3]
Eastell R(2014)Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 29 1-21
[4]
Takahashi M(2015)Imaging findings and evaluation of metabolic bone disease Adv Radiol 2015 1-4492
[5]
Ozaki Y(2013)The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension J Clin Endocrinol Metab 98 4483-4
[6]
Kizawa R(2013)An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab Case Rep Rheumatol 2013 1-47
[7]
Shane E(2014)Bilateral atypical femoral fractures in a patient prescribed denosumab—a case report Bone 61 44-358
[8]
Burr D(2014)Atypical femoral fracture in a patient treated with denosumab J Bone Miner Metab 33 355-7
[9]
Abrahamsen B(2014)Atypical fracture of the femur in a patient using denosumab—a case report Acta Orthop 85 6-5
[10]
Adler RA(2013)Atypical femoral fractures bilaterally in a patient receiving denosumab Acta Orthop 85 3-825